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Abstract
Background: RNA amplification is necessary for profiling gene expression from small tissue
samples. Previous studies have shown that the T7 based amplification techniques are reproducible
but may distort the true abundance of targets. However, the consequences of such distortions on
the ability to detect biological variation in expression have not been explored sufficiently to define
the true extent of usability and limitations of such amplification techniques.
Results: We show that expression ratios are occasionally distorted by amplification using the
Affymetrix small sample protocol version 2 due to a disproportional shift in intensity across
biological samples. This occurs when a shift in one sample cannot be reflected in the other sample
because the intensity would lie outside the dynamic range of the scanner. Interestingly, such
distortions most commonly result in smaller ratios with the consequence of reducing the statistical
significance of the ratios. This becomes more critical for less pronounced ratios where the evidence
for differential expression is not strong. Indeed, statistical analysis by limma suggests that up to 87%
of the genes with the largest and therefore most significant ratios (p < 10e-20) in the unamplified
group have a p-value below 10e-20 in the amplified group. On the other hand, only 69% of the more
moderate ratios (10e-20 < p < 10e-10) in the unamplified group have a p-value below 10e-10 in the
amplified group. Our analysis also suggests that, overall, limma shows better overlap of genes found
to be significant in the amplified and unamplified groups than the Z-scores statistics.
Conclusion: We conclude that microarray analysis of amplified samples performs best at
detecting differences in gene expression, when these are large and when limma statistics are used.
Background
Microarray technology offers a high throughput approach
to transcriptional profiling on a genome wide scale. How-
ever, the relatively large amount of starting material
required for standard hybridization has limited its full
potential. In complex biological systems such as the nerv-
ous system, the utility of this approach is complicated by
the fact that even in anatomically discrete regions, many
divergent cell types are intermingled. It is often desirable
to investigate gene expression profiles of distinct cell types
Published: 09 October 2006
BMC Genomics 2006, 7:252 doi:10.1186/1471-2164-7-252
Received: 01 September 2006
Accepted: 09 October 2006
This article is available from: http://www.biomedcentral.com/1471-2164/7/252
© 2006 Diboun et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 14
(page number not for citation purposes)
BMC Genomics 2006, 7:252 http://www.biomedcentral.com/1471-2164/7/252and although laser microdissection provides a solution to
the problem of tissue procurement, the small amount of
RNA that can be harvested has precluded a straightfor-
ward combination of both technologies. This limitation is
compounded by the need of replication essential for sta-
tistical analysis.
Another scenario in which the lack of sufficient tissue
availability has been challenging is the correlation of the
phenotype in individual experimental animals with com-
prehensive gene expression profiles. For example, so far it
has not been possible to correlate the inter-individual
behavioural variability in animal models of chronic pain
with the corresponding correlates in gene expression in
the principal anatomical components of the pain pathway
as such structures in individual animals do not yield suffi-
cient amounts of RNA for standard hybridization proto-
cols.
To overcome these issues, increasingly sophisticated
approaches to RNA amplification from small tissue sam-
ples have been developed for use with microarrays. These
fall principally into two categories. One is based on PCR
and is characterized by an exponential increase in copy
number while the other is based on the T7-polymerase in-
vitro transcription (IVT) to achieve a linear amplification
of targets. For maximum fidelity, linearity of target ampli-
fication is desirable. Thus, substantial work has focused
on exploring the T7 linear techniques [1-4], in particular
the Affymetrix small sample protocol II has been assessed
by numerous studies with interesting results. Analysis
based on correlating intensity levels and assessing con-
cordance in detection calls has indicated a high level of
reproducibility [2,3,5,6]. However, occasional failure to
maintain the true abundance level of transcripts was also
found [3,5,6] due to the protocol 3'bias [1,2,4,6,7]. Such
bias is thought to be related to the use of random hexam-
ers to prime the RT reaction in the additional round of
amplification. With priming that is remote from the
3'end, RT may not be successfully completed causing a
diminution in the signal from the 5' regions.
These observations are useful indicators of protocol valid-
ity; though, the ultimate fidelity criterion is the ability to
maintain differential expression between different tissues
or under varying experimental conditions. Some previous
studies have reported a 50% drop in significant changes in
gene expression using RNA amplification [4], suggesting
that RNA amplification may suffer major problems and is
potentially unsuitable for microarray analysis.
In this study, we critically appraise the suitability and mer-
its of transcript amplification from small biological sam-
ples for microarray expression profiling using the
Affymetrix small sample protocol II. We confirm previous
findings on the reproducibility and fidelity of the proto-
col. We present compelling evidence for the 3' bias intro-
duced by RNA amplification. We show how distortions in
intensity may be reflected in the expression ratios from
biologically different samples. Importantly, we explore
the effect of distortions in expression ratios on their statis-
tical significance.
Results
In this study, we undertake a detailed analysis of target
amplification for microarrays using the Affymetrix small
sample protocol II. This analysis was performed using
control data from standard protocol preparations as refer-
ence. For the rest of the article, we refer to the standard
protocol as the OneRA (one round amplification) proto-
col and the small sample protocol as the TwoRA (two
rounds amplification) protocol. TwoRA and OneRA sam-
ples from three different biological groups were used in
this study: the DRG (dorsal root ganglia) group, the SN
(spinal cord from normal animals) group and the SA (spi-
nal cord from animals with axotomised sciatic nerve)
group. In each group, there are 4 replicates from the
TwoRA and 3 replicates from the OneRA (Figure 1a).
While, the main objective of this study is to assess the
extent to which biologically relevant variation in gene
expression can be detected in the TwoRA, we begin by
assessing the reproducibility of the TwoRA protocol and
its fidelity in maintaining the relative abundance of tar-
gets.
Reproducibility and fidelity in maintaining expression 
levels
Scatter plots of log2 intensities from paired TwoRA repli-
cates show expectedly high level of consistency similar to
that observed with the OneRA replicates (Figure 1b &1c)
((r) ranging from 0.990 to 0.994 among all possible pairs
of the TwoRA replicates and the OneRA replicates from all
biological groups). However, comparing the average log2
intensity values from the OneRA and the TwoRA (Figure
1d) for a single tissue, we see evidence of variability
implying that the TwoRA protocol may distort the signal.
We used an ANOVA approach to confirm that the variabil-
ity between protocol groups is greater than that among
replicates within each group. In particular, a one-way,
two-levels ANOVA analysis was performed for each gene
separately, with 3 measurements from the OneRA (level
1) and 4 measurements from the TwoRA (level 2). First,
the between group mean sum of squares MSA as well as
the mean residual sum of squares MSE were calculated.
The median of the MSA was higher than the median of the
MSE (given in parenthesis) in all biological groups: DRG
0.050 (0.023), SN 0.062 (0.016), SA 0.068.Page 2 of 14
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than the residual variability, we derived p-values from the
F-values (MSA/MSE) for each gene (using the upper tail of
an F-distribution with 1 and 3 + 4 – 2 degrees of freedom).
In fact, the p-values were far from uniformly distributed.
Storey suggests the following estimate of the proportion
of hypotheses from the null using p-values: the fraction of
p-values above the median p-value m, divided by (1-m)
[38]. This results in the following estimate of the propor-
tion of genes with significantly higher amplification vari-
ability: DRG 47%, SN 50%, SA 41%. That is, in all cases at
least 40% of genes show differences between protocols,
which are not explained by variability within replicates.
Signal distortion following TwoRA
To investigate signal distortion by the TwoRA protocol, we
looked at the well-documented 3' bias feature of the pro-
tocol in the DRG dataset (similar results were obtained
with the SA and SN). Bias arises from greater 3' represen-
tation of targets during TwoRA while 5' regions are often
lost. This causes amplified RNA to be shorter than normal.
Previously published work explored the increase in the 3'/
5' signal ratios only from control genes (GAPDH, Actin)
to prove that such effect occurred)[2,4,7]. In this study, we
undertook a more comprehensive analysis by using infor-
mation from all probesets on the array. More specifically,
we correlated the deviation in log2 intensity following
TwoRA (Δlog2IN) – obtained by subtracting the log2
intensity in the OneRA from that of the TwoRA – with the
probesets 3' locations on corresponding targets (see meth-
ods for a description of how these locations were
obtained) (Figure 2). The trend suggests that probesets
distal from the 3' end are more likely to endure an atten-
uation of signal intensity following TwoRA whilst those
close to the 3' end are likely to show intensification of sig-
nal.
A, experimental designFigure 1
A, experimental design. B&C&D, correlation of log2 intensities within and between protocol groups. B&C, scat-
ter plots of log2 signal intensities from a pair of replicates treated with the OneRA and the TwoRA protocol respectively. D, 
scatter plot of log2 signal intensities averaged across the OneRA replicates versus that from the TwoRA replicates. The coeffi-
cient of correlation (r) value is given for each pair. Similar results were obtained with the SN and SA sample groups.Page 3 of 14
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lute Δlog2IN values were greater than 2 were reviewed for
their 3' location distribution (Figure 3). This was com-
pared to the distribution of 3'location of all probesets on
the array. The distribution for all probesets appears to be
skewed and peaks at around 600 bp. The distribution of
probesets with intensified signal shows an additional
peak to the left suggesting a distinct population of
probesets closer than average to the 3' end (Figure 3a).
This is further highlighted by a decrease in the 25% quan-
tile relative to the overall population in the boxplots on
figure 3c. Conversely, the distribution from probesets
with attenuated signal shows a second peak to the right
indicating an overrepresentation of more distal interroga-
tion points relative to the 3' end of targets (Figure 3b).
This corresponds to an increase in the 75% quantile (Fig-
Deviation in log2 intensity following TwoRA (Δlog2IN) as a function of probeset 3' distance rankFigure 2
Deviation in log2 intensity following TwoRA (Δlog2IN) as a function of probeset 3' distance rank. Δlog2IN values 
on the y-axis were calculated by subtracting the mean OneRA from the mean TwoRA probeset log2 intensities. The x-axis 
shows the ranks of probesets locations. Probesets locations are relative to the 3' end of the transcripts (refer to methods for 
more details). Since the probesets locations have a skewed distribution, their ranks were plotted instead of their absolute val-
ues; this allows dispersion of data points. The actual probesets locations that correspond to the rank intervals on the x-axis are 
shown on the blue horizontal axis on the top of the figure. The regression line is shown in red. Only data from the DRG prep-
aration were used, similar results were obtained with the SN andPage 4 of 14
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severe signal distortions following TwoRA are strongly
associated with 3' positional bias.
Interestingly, with both populations of deviant probesets
(Figure 3a &3b), there is a peak that overlaps with that
from the distribution of the average population. This
Distribution of 3' distances from probesets with the most discrepant signal intensity following TwoRA (absolute Δlog2IN >= 2)Figure 3
Dist ribution of 3' distances from probesets with the most discrepant signal intensity following TwoRA (abso-
lute Δlog2IN >= 2). A&B, histograms of 3' locations from the probesets at large represented on the MOE430A chip (green) 
versus those showing at least 2 fold change in log2 signal intensity following TwoRA (increase/decrease in signal, red/blue 
respectively). (Solid line), DRG. (Dashed lines), SA. (Dotted lines), SN. Arrows indicate additional peaks in the distributions 
apart from that of the overall population. C, a box and whisker plot showing the 0% and 100% quantiles as whiskers, the 25% 
and 75% quantiles as boxes and the 50% quantile as horizontal dash within the box. The plot summarises the distributions 
shown in A and B. One the y-axis, (+) indicates increase in signal intensity following TwoRA, (-) indicates decrease in signal 
intensity following TwoRA. Note that for all plots, probesets locations are in base pairs and relative to the 3' end of targets.Page 5 of 14
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population that is at the same distance from the 3' end as
the general population; yet, their intensities are shifted in
the TwoRA. This suggests that other factors, apart from
3'bias, are likely to be involved in distorting the signal.
One possible factor is the abundance of the transcript.
Thus, we correlated the deviation in log2 intensity follow-
ing amplification (Δlog2IN) with the log2 intensity for
the DRG, OneRA (Figure 4). The plot indicates some bias
in the extreme Δlog2IN values along the intensity scale.
This is due to the fact that the intensity range is limited; in
other words, intensity cannot be higher than the satura-
tion level (ceiling effect) or below background noise
(floor effect).
Fidelity in maintaining expression ratios
The ultimate aim of microarrays is the identification of
differential expression. Thus, a good amplification proto-
col should faithfully maintain expression ratios. To verify
this, we cross-compared expression ratios from biologi-
cally distinct tissue samples treated with the OneRA and
the TwoRA protocols.
First, we considered the (SA,SN) pair. Expression ratios on
log2 scale from the OneRA samples were correlated with
their equivalents from the TwoRA (Figure 5a). The signif-
icant changes in expression (labelled in figure 5a) seem to
be consistent in the TwoRA and the OneRA groups. These
are well documented in the literature (activating transcrip-
tion factor 3 [19] and small proline-rich repeat protein 1A
[20]). However, there are relatively few differences in gene
expression between these two biological samples, proba-
bly due to the fact that the tissue from the injured animals
included areas of the spinal cord not affected by the axot-
omy, which could have caused a dilution of effect in the
relevant areas. To reliably evaluate the effect of the TwoRA
Deviation in log2 intensity following TwoRA (Δlog2IN) versus the OneRA log2 intensityFigure 4
Deviation in log2 intensity following TwoRA (Δlog2IN) versus the OneRA log2 intensity. The dashed lines in red 
show roughly the limits of the intensity range, thus the upper line represents saturation while the lower line represents back-
ground noise. The analysis was done on the DRG data; similar results were obtained with the SN and SA samples.Page 6 of 14
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Correlation of log2 expression ratios from the OneRA and TwoRA and that of Δlog2IN from the two compared samplesFigure 5
Correlation of log2 expression ratios from the OneRA and TwoRA and that of Δlog2IN from the two com-
pared samples. A&C, scatter plots of log2 expression ratios from the OneRA and the TwoRA for the (SA,SN), (DRG,SN) 
pairs respectively. For instance, the log2 OneRA expression ratio for the (DRG,SN) pair is log2 OneRA DRG – log2 OneRA 
SN. For the (SN, SA) pair, the most significant differences in gene expression (ATF3 and SPRR1A) are consistent in both pro-
tocol groups. For the (DRG,SN), the ratios are more varying, the regression line (shown in blue) appears to be shifted from 
the diagonal towards smaller values of expression ratios in The TwoRA. B&D, scatter plots of Δlog2IN values for the 
(DRG,SN) pair and the (SA,SN) pair respectively. Δlog2IN were calculated by subtracting the log2 OneRA intensity from the 
log2 TwoRA intensity. Points in red in 'C' are probesets where the intensity in one sample could not be shifted as much as in 
the other sample because the intensity cannot lie outside the dynamic range of the scanner. These are referred to as FCE 
(floor & ceiling effect) probesets and have varying expression ratios following TwoRA. The FCE probesets also show the most 
varying DRG and SN Δlog2IN values (points in red, D). Though, for these same probesets, the Δlog2IN values in the SA and 
the SN are fairly consistent (points in red, B).
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sion is needed. This was possible with the (DRG,SN) pair.
Thus, we decided to base our assessment of the effect of
the TwoRA on ratios on the (DRG,SN) dataset.
Encouragingly, log2 expression ratios from the (DRG,SN)
treated with the OneRA and the TwoRA protocols are
comparable; though they show more variability than their
counterparts from the (SA,SN) pair (Figure 5c). Moreover,
the regression line (shown in blue) appears to be shifted
from the diagonal in a way that suggests that the expres-
sion ratios are on average slightly lower in the TwoRA rel-
ative to the OneRA.
Variation in ratios
From our previous analysis, we know that the TwoRA pro-
tocol may shift the absolute intensity levels. However, this
only affects expression ratios if the intensity is shifted une-
qually in the two biological samples. That is, deviations in
intensity (Δlog2IN) following TwoRA, that differ in the
two samples, can result in variability in the expression
ratios from the OneRA and the TwoRA groups.
To get further insights into how unequal shifts in the
intensity level following amplification of different biolog-
ical samples affect the expression ratios, we ranked
probesets by the absolute difference in their OneRA and
TwoRA log2 expression ratios and selected the top 100 for
further analysis (partly listed in Table 1). Specifically, we
examined the intensities of these selected probesets across
all four groups: the OneRA and the TwoRA DRG, SN. The
resulting intensity profiles were classified into four catego-
ries depending on the direction of change in intensity and
the tissue where this change occurred (Figure 6). The most
populated categories show a significant reduction in the
intensity in one of the samples whilst the intensity in the
other sample is minimally reduced (Figure 6a &6c). Less
frequently, the intensity increases with amplification in
one of the samples but not in the other sample (Figure 6b
&6d).
Interestingly, with all four categories, expression ratios are
reduced following TwoRA. Moreover, the majority of the
selected probesets have varying intensity levels in the DRG
versus SN, OneRA. Frequently these genes are absent in
one sample but highly expressed in the other sample
(shown as coloured lines in figure 6), which may explain
the deviation in expression ratios following TwoRA. If one
takes the example of HipK2, the log2 intensity in the SN
was reduced from 8.20 in the OneRA to 0.73 in the
TwoRA. However, HipK2 is absent in the DRG (the
OneRA log2 intensity is 0.87), thus an equivalent reduc-
tion in the intensity level in this sample is not possible
(floor effect). As such the log2 expression ratio is shifted
from -7.33 in the OneRA to 0.15 in the TwoRA. Alterna-
tively, in other cases, if amplification increases the inten-
sity in one sample, an equal shift in the other sample
would not be possible if the intensity was close to satura-
tion (ceiling effect).
Thus, distortions in the expression ratios may occur when
a shift in intensity (Δlog2IN) in one sample cannot be
mirrored in the other sample because it would cause the
intensity to fall outside the dynamic range of the scanner.
This relates to the previous analysis presented in Figure 4.
Certainly, this phenomenon does not apply to genes with
similar intensity levels in the two samples since a shift in
intensity in one sample is equally possible in the other
sample.
To assess the extent to which this phenomenon explains
the deviation in expression ratios observed across the
Table 1: Summary of the top 10 discrepant probesets whose (DRG,SN) expression ratios from the TwoRA deviate most from the 
OneRA.
ProbeSet ID (Gene Symbol) Log 2 intensity
DRG SN SA
1R 2R 1R 2R 1R 2R
1425983_x_at (Hipk2) 0.87 0.89 8.20 0.73 7.79 0.70
1422277_at (Glra1) 2.35 2.40 9.65 2.46 9.87 2.46
1422009_at (Atp1b2) 2.98 2.56 12.73 5.50 12.57 4.49
1450177_at (Ngfr) 8.98 2.63 2.25 2.33 2.23 2.27
1425337_at (Slc12a5) 2.34 2.33 9.89 3.50 9.63 3.54
1425963_at (Cabp7) 1.94 1.98 7.88 2.07 7.80 2.03
1439083_at (Ahi1) 2.14 2.17 7.77 2.05 7.96 2.54
1429566_a_at (Hipk2) 1.62 1.55 11.01 5.60 10.78 5.71
1456637_at (Lrrtm2) 8.57 3.35 3.92 4.00 4.59 4.07
1423669_at (Col1a1) 11.06 5.86 2.76 2.81 2.74 2.74
Listed are gene annotations (probeset ID and gene symbol) and log2 intensities from all biological versus protocol groups.Page 8 of 14
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tive analysis. We selected all probesets where a shift in
intensity following TwoRA in one sample would cause the
intensity in the other sample to fall outside the intensity
range, that is below the background noise or higher than
the saturation level. These limits were chosen to be the 3%
and 98% quantiles of the distribution of signal intensity
on the chip, respectively. The analysis was conducted by
first determining the maximum Δlog2IN (log2 TwoRA –
log2 OneRA) across the two samples for each gene. Thus,
if the maximum Δlog2IN is found in sample A, we add the
same Δlog2IN to the OneRA log 2 intensity from sample
B. If the resulting value is outside the chosen limits, the
probeset is selected by our analysis.
Intensity profiles of probesets with top 100 most deviant expression ratios following TwoRAFigure 6
Intensity profiles of probesets with top 100 most deviant expression ratios following TwoRA. The profiles are 
classified into four categories: A&C, the intensity is reduced in the tissue sample where the gene is more expressed (DRG, SN 
respectively). B&D, the intensity is increased in the sample where the gene is less expressed (SN, DRG respectively). Solid lines 
mark the shift in intensity from OneRA to TwoRA for one tissue sample. Dashed lines link the intensity data for equivalent 
probesets in the two biological samples. In colour are probesets with absent call 'A' in the SN (red) and DRG (blue).Page 9 of 14
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effect, we shall refer to them as FCE probesets for the rest of
the article. Clearly, the FCE probesets are the same
probesets that show the most deviant expression ratios
following TwoRA (coloured in red, Figure 5c) and corre-
spondingly the most pronounced variation in shifts in
intensity (Δlog2IN) in the DRG and SN samples (in red,
Figure 5d). In fact, the correlation in the (DRG,SN)
expression ratios across protocols (r) = 0.89 is improved
to 0.93 when the FCE probesets are excluded. Interest-
ingly, we found that the FCE probesets show consistent
Δlog2IN following TwoRA in the SA and SN groups (in
red, Figure 5b). This is because their intensities are similar
in the (SA,SN) but different in the (DRG,SN) datasets.
Similarity in inferring significance in ratios
The primary aim of a microarray experiment is to detect
significant changes in gene expression. Our results suggest
that ratios are most commonly reduced among the genes
with large expression ratios in the OneRA, thus likely to be
differentially expressed. Indeed, we found good evidence
from the literature to suggest that 9 genes of those with the
10 most discrepant ratios following TwoRA are indeed dif-
ferentially expressed between the SN and DRG (Table 2).
Despite reductions in the ratios, genes can remain signifi-
cant following TwoRA if their ratios are still large relative
to the average population in the TwoRA. Moreover,
among the population of genes with high expression
ratios in the OneRA (Figure 5c), many do maintain their
ratios in the TwoRA, most likely due to a faithful TwoRA
of the transcripts in the two biological samples.
Table 2: Evidence of differential expression for the genes with the 10 most discrepant (DRG,SN) tissue ratios from the OneRA and the 
TwoRA.
ProbeSet ID Gene Symbol) Log2 expression ratios Evidence for differential expression
OneRA TwoRA
1425983_x_at (Hipk2) -7.33 0.15 Hipk2 encodes Homeodomain-interacting protein kinase 2. On the chip, there are 
two interrogation sites and in both the results from the OneRA indicates that the 
gene is more strongly expressed in the spinal cord. In the embryo, Hipk2 is 
expressed in DRG and spinal cord [24] but it is strongly downregulated prenatally in 
sensory neurons [25]. Judging from LacZ expression in transgenic mice, Hipk2 is 
highly expressed in the spinal cord, especially in the motor neurons [26].
1429566_a_at (Hipk2) -9.40 -4.06
1422277_at (Glra1) -7.29 -0.06 Glra1 encodes the alpha1 subunit of the glycine receptor. Although it is found in 
some neurons of the DRG, it is very strongly expressed in the spinal cord [27].
1422009_at (Atp1b2) -9.75 2.94 ATP1b2 encodes the beta2 subunit of the Na+/K+ transporting ATPase, which is 
mainly located in glial cells [28]. It is not found in the DRG using 
immunohistochemistry [29].
1450177_at (Ngfr) 6.73 0.30 Ngfr encodes the low affinity neurotrophin receptor p75. In the adult it is expressed 
in many neurons of the DRG [30], but largely absent in the spinal cord [31]. A 
second probeset (ID: 1421241_at) interrogating the same gene reported similar 
results i.e. the log2 expression ratio in the TwoRA is reduced (3.62, 0.22 OneRA, 
TwoRA respectively).
1425337_at (Slc12a5) -7.54 1.16 Slc12a5 is the Solute carrier family 12 member 5, also known as the Neuronal K-Cl 
cotransporter 2 (KCC2). It is strongly expressed in neurons of the adult CNS 
including the spinal cord but it is absent in DRG neurons [32].
1425963_at (Cabp7) -5.95 -0.09 Cabp7 encodes the calcium binding protein 7, which is strongly expressed in spinal 
cord [33].
1439083_at (Ahi1) -5.63 0.12 Ahi1, Abelson helper integration site 1, encodes a cytoplasmic adaptor protein [34]. 
It is primarily expressed in the CNS including the spinal cord [35]. Mutation of this 
gene causes Joubert syndrome, a congenital malformation of the cerebellum and 
brainstem with axonal decussating abnormalities of the corticospinal tract [35].
1456637_at (Lrrtm2) 4.65 -0.65 Lrrtm2 is leucine-reach repeat protein 2, also known as neuronal leucine-rich repeat 
protein 2. It is found in DRG and spinal cord [36] and on the basis of available in situ 
hybridisation data appears to have stronger expression in the DRG than in spinal 
cord [36].
1423669_at (Col1a1) 8.30 3.05 Col1a1, is collagen type 1. It is ubiquitously expressed, but prominent in bone and 
connective tissue. It is possible that the increase in the DRG sample is due to a 
contamination during the dissection of the DRG (which were harvested after cutting 
the vertebral column).
The genes have large expression ratios in the OneRA that are reduced in the TwoRA. The log2 expression ratios are calculated as log2 intensity 
from the DRG group – log2 intensity from the SN group. Thus, if the ratio is positive, the gene is more expressed in the DRG whilst if negative, the 
gene is more expressed in the SN.Page 10 of 14
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limma) to identify transcripts differentially expressed in
the (DRG,SN) tissue samples prepared with both proto-
cols (One RA and TwoRA). With each statistical method,
an FDR based multiple testing correction was used and
genes were ranked by their FDR values in ascending order.
To measure the extent of agreement between protocols
over genes identified as significant, we defined the signifi-
cance similarity score (or the SSS) as the proportion of
genes common to subsets of highly ranked genes from the
OneRA and the TwoRA (DRG,SN) comparisons. The
results are summarised in Table 3. Higher SSS were
obtained using limma compared to the Z-scores method.
With limma, 87 out of the top 100 most significant genes
were common to the OneRA and the TwoRA comparisons
as oppose to 59 using Z-scores statistics.
For a more global assessment of the effect of distortions in
expression ratios on their statistical significance, we used
a scatter plot of negated log p-values (nlPv) from the
limma analysis of the OneRA and the TwoRA (DRG,SN)
(Figure 7). The FCE probesets are highlighted in red on
figure 7 and it can be seen that their nlPv are least corre-
lated between the two protocols, due to distortions in the
expression ratios (scatter on figure 5c). Amongst the FCE
probesets, some still show reasonable nlPv following
TwoRA (> 10). Inspection of these genes revealed that
they have large expression ratios in the OneRA and mod-
erate ratios in the TwoRA (the median log2 expression
ratios was 5.09, 2.52 respectively). By contrast, those FCE
probesets with low nlPv (< 10) in the TwoRA have had
their log2 expression ratios reduced severely following
TwoRA (median log2 ratio in the TwoRA = 0.43).
Interestingly, the latter have, on average, moderate expres-
sion ratios in the OneRA (median log2 ratio in the OneRA
= 2.8). This is expected since with moderate expression
ratios, any reduction would have a greater impact on their
significance level. Indeed, looking at the whole popula-
tion of probesets, out of those with a nlPv between 10 and
20 in the OneRA, only 69% have an nlPv above 10 in the
TwoRA, compared to probesets with high nlPv (> 20) in
the OneRA where 87% (in agreement with previous
results, Table 3) of them have nlPv above 20 in the
TwoRA. This suggests that the TwoRA protocol is more
suitable with experiments where large differences in gene
expression are occurring.
Discussion
Microarray technology is currently limited by the need for
relatively large transcript quantities, which makes it inca-
pable of handling small biological samples. The T7 in-
vitro transcription has been widely explored to achieve a
linear amplification of targets for microarrays. Much work
has considered the effect of linear amplification on the
ability to profile gene expression. Although, the reproduc-
ibility of such techniques and their fidelity in maintaining
absolute levels of expression have been extensively ana-
lysed, much less is known about their ability to accurately
reproduce differential expression in distinct biological
samples. This study gives further insights on the impact of
linear amplification using the Affymetrix small sample
protocol on expression ratios and differential expression.
Our analysis confirms the high reproducibility of the
small sample TwoRA protocol and the occasional failure
in its fidelity to maintain the original levels of gene expres-
sion. In this study, robust analyses were used to confirm
the 3' bias role in signal distortion. Instead of limiting our
analysis to control genes, as previously undertaken by
other groups [2,4,6,7], evidence was obtained by exami-
nation of intensity data from all probesets on the array. In
addition to 3'bias, this work has explored the relationship
between distortions in signal intensity following TwoRA
and the original intensity level prior to TwoRA. The fact
that the intensity range is limited by background noise on
one end and saturation on the other end implies that
intensity may only be shifted by a limited amount. This
relationship bears important consequences on the con-
sistency of the TwoRA protocol in amplifying targets with
varying intensities across different samples. Thus, the
shifts in intensity following amplification will not appear
to be equivalent in the two samples if the shift in one of
the samples is limited by the range of the scanner. This has
Table 3: Similarity in significance calls from the OneRA and the TwoRA (DRG,SN) comparisons using the Z-scores and limma 
statistics.
Number of top significant genes Z-scores Limma
SSS(%) FDR SSS (%) FDR
OneRA TwoRA OneRA TwoRA
100 59 3.7E-3 1.1E-2 87 5.23E-14 1.72E-14
300 59 7.1E-2 0.11 87 2.08E-12 6.56E-13
500 63 0.201 0.214 87 1.52E-11 5.59E-12
The significance similarity score (SSS) is the percentage of genes common to the OneRA and the TwoRA selected sets of top significant genes.Page 11 of 14
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clearly demonstrated by our data.
Unsurprisingly, the statistical significance of expression
ratios is only affected when the expression ratio in the
TwoRA is reduced to the point where it can no longer be
distinguished from noise. Importantly, large ratios are less
likely to be critically diminished and more likely to
remain significant following TwoRA. This explains why
despite the distortions in ratios in our dataset, there was
up to 87% agreement in the top significant genes (nlPv >
20) from the TwoRA and OneRA (DRG,SN). On the other
hand, less agreement was observed among the less pro-
nounced ratios (69%) since distortions are more critical.
This leads us to the important conclusion that TwoRA
may affect the statistical significance of genes with moder-
ate expression ratios to a greater extent. Another impor-
tant finding by this study is that limma performs best at
recognising similarity in differential expression between
the OneRA and the TwoRA. Thus, the choice of statistics
will also affect the quality of information obtained from
microarray analysis of amplified samples.
Conclusion
We conclude that the Affymetix small sample amplifica-
tion protocol is useful with the following caveats: First, it
should be only used when tissue homogeneity is a crucial
factor and sufficient amounts of starting material cannot
be obtained by any other means. Secondly, target amplifi-
cation using the small sample protocol appears to be suit-
able in situations where big differences in gene expression
are expected. Fortunately, it is reasonable to expect large
differential expressions with experiments characterising
different cells within a mixed tissue where amplification
of transcript is necessary. Finally, application of such tech-
nique in combination with limma statistical analysis is
useful in experiments where the ultimate purpose is to
experimentally characterise a finite number of targets, for
example the top 100 differentially expressed genes.
However, expression data obtained from amplified sam-
ples might be less suitable for more comprehensive
numerical analysis, for example characterising regulatory
networks, due to the problems caused by possible shifts in
signal and expression ratios.
Methods
- Tissue isolation and RNA extraction
Three pools of tissue were prepared from C57/B6 adult
male mice after cervical dislocation or decapitation. Tissue
from each animal was dissected within 10 minutes of kill-
ing and collected on dry ice. One sample consisted of dor-
sal root ganglia (DRG) of all spinal levels from 10 naïve
mice. Another sample (SA) was the lumbar enlargement
of the spinal cord of 5 animals that had undergone a uni-
lateral sciatic nerve transection at mid-thigh level under
isoflurane anesthesia 7 days previously. A third sample
(SN) was the lumbar enlargement of the spinal cord of 5
normal mice. RNA was prepared using the Trizol method
(Invitrogen) followed by a cleanup step using the RNAe-
asy Mini kit (Qiagen). RNA quality and quantity was
measured by microfluidic electrophoresis (Nanochip run-
ning on a 2100 Bioanalyzer, Agilent Technologies, Palo
Alto, USA). The 28S/18S RNA ranged from 1.3 to 1.4 in all
samples. The total amount of RNA was 42.2 μg, 40.1 μg,
and 25.3 μg for the DRG, SN, SA samples respectively. The
corresponding RNA integrity numbers (RINs) were 8.3,
9.3 and 9.4. RINs larger than 8 are considered to be perfect
for downstream applications [37].
- RNA amplification and chip hybridisation
RNA processing and hybridization followed the Affyme-
trix methodology. In brief, the Affymetrix standard proto-
col [8] (in the article referred to as the OneRA protocol)
was used to generate three labelled cRNA samples from
each tissue pool using 5 μg of total RNA as starting mate-
rial (Figure 1a). The Affymetrix small sample protocol ver-
sion 2 [9] (referred to as the TwoRA protocol) that
Effect of variation in expression ratios on their statistical sig-ni icanceFigure 7
Effect of variation in expression ratios on their statis-
tical significance. Scatter plots of FDR corrected nlPv 
(negated log transformed p-value) from the Limma analysis of 
the OneRA and the TwoRA DRG and SN samples. As a 
result of negating the p-values, large nlPv indicate stronger 
evidence of differential expression. Data points in red repre-
sent the FCE probesets. The dashed line is at nlPv = 10 in the 
TwoRA, above which genes may be considered significant.Page 12 of 14
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4 labelled samples using 50 ng of starting material from
each pool (Figure 1a). The quality of cRNA from all tissue
pools and various treatments was assessed using microflu-
idic electrophoresis. Similar profiles were obtained,
although there was a significant shift towards smaller RNA
fragments with the TwoRA protocol. Material from the 21
target preparations was then hybridized to MOE430A
chips.
- Data capture and data processing
Scanned images were first inspected for quality control
(QC) using a variety of built-in QC tools from the Biocon-
ductor package [10] of R, the open source environment
for statistical analysis. QC consisted of visual examination
of probe array images, scatter plots from replicates, hierar-
chical clustering of array hybridizations, RNA degradation
plots and MvA plots. Feature intensity values from
scanned arrays were normalised and reduced to expres-
sion summaries using the GC Robust Multiarray Algo-
rithm (GCRMA) [11,12] implemented as a function in the
Bioconductor GCRMA library [13]. Detection calls indi-
cating the presence or absence of signal from each probe
set were obtained by processing the raw data with the
Microarray Analysis Suite 5.0 (MAS5). To obtain a consen-
sus detection call across replicate hybridizations, a probe
set was considered to be present if it received a P (present)
detection call from all replicates or n-1 replicates with an
M (marginal) call from the remaining replicate. A
(absent) detection calls were determined in the same way.
For further analysis, probesets 3' locations were obtained
by downloading the MOE430a probe tab files made avail-
able by the Affymetrix online support [39]. A probeset
location was considered equal to the 3' distance of the
probe that is most distal from the 3' end of the corre-
sponding target within the set.
To test for differential expression, two statistical methods
were used. The bayesian adjusted t-statistics from the lin-
ear models for Micoarray data (limma) package [14,15]
and the Z-scores method as described by Quackenbush
[16]. With both methods, a multiple testing correction
based on the false discovery rate (FDR) was performed.
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